Clinical trial
Anecortave Acetate Risk-Reduction Trial (AART)
NCT00307398 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anecortave Acetate Risk-Reduction Trial (AART)
- Lead sponsor
- Alcon Research
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- March 31, 2004
- Completion date
- January 31, 2009
- Enrollment
- 2,596 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dry amd